{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:28:39Z","timestamp":1786429719734,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2022JM-559, 2025JC-YBMS-956"],"award-info":[{"award-number":["2022JM-559, 2025JC-YBMS-956"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10863-026-10121-1","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:45:20Z","timestamp":1786427120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["M2 macrophage-derived exosomal EHF transcriptionally activates FGFR1 to promote malignant phenotypes and glycolysis in NSCLC"],"prefix":"10.1007","volume":"58","author":[{"given":"Dan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"10121_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nrc.2017.8","volume":"17","author":"IS Babina","year":"2017","unstructured":"Babina IS, Turner NC (2017) Advances and challenges in targeting FGFR signalling in cancer. Nat Rev Cancer 17:318\u2013332","journal-title":"Nat Rev Cancer"},{"key":"10121_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40478-020-00898-6","volume":"8","author":"TA Bale","year":"2020","unstructured":"Bale TA (2020) FGFR- gene family alterations in low-grade neuroepithelial tumors. Acta Neuropathol Commun 8:21","journal-title":"Acta Neuropathol Commun"},{"key":"10121_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1615\/CritRevOncog.2024053830","volume":"29","author":"I Bui","year":"2024","unstructured":"Bui I, Bonavida B (2024) Polarization of M2 Tumor-Associated Macrophages (TAMs) in Cancer Immunotherapy. Crit Rev Oncog 29:75\u201395","journal-title":"Crit Rev Oncog"},{"key":"10121_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/jcmm.17094","volume":"26","author":"JY Chen","year":"2022","unstructured":"Chen JY, Chen YJ, Liu L, Jin XX, Shen Z, Chen WB et al (2022) C1632 suppresses the migration and proliferation of non-small-cell lung cancer cells involving LIN28 and FGFR1 pathway. J Cell Mol Med 26:422\u2013435","journal-title":"J Cell Mol Med"},{"key":"10121_CR5","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1007\/s11010-024-05161-3","volume":"480","author":"H Fang","year":"2025","unstructured":"Fang H, Chi X, Wang M, Liu J, Sun M, Zhang J et al (2025) M2 macrophage-derived exosomes promote cell proliferation, migration and EMT of non-small cell lung cancer by secreting miR-155-5p. Mol Cell Biochem 480:3019\u20133032","journal-title":"Mol Cell Biochem"},{"key":"10121_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3892\/or.2021.8053","volume":"45","author":"L Gao","year":"2021","unstructured":"Gao L, Yang T, Zhang S, Liang Y, Shi P, Ren H et al (2021) EHF enhances malignancy by modulating AKT and MAPK\/ERK signaling in non\u2013small cell lung cancer cells. Oncol Rep 45:102","journal-title":"Oncol Rep"},{"key":"10121_CR7","doi-asserted-by":"publisher","first-page":"1485661","DOI":"10.3389\/fphar.2025.1485661","volume":"16","author":"Y Gao","year":"2025","unstructured":"Gao Y, Xie J, Yang Z, Li M, Yuan H, Li R (2025) Functional tumor-derived exosomes in NSCLC progression and clinical implications. Front Pharmacol 16:1485661","journal-title":"Front Pharmacol"},{"key":"10121_CR8","doi-asserted-by":"publisher","first-page":"7138","DOI":"10.3390\/ijms23137138","volume":"23","author":"B Han","year":"2022","unstructured":"Han B, Molins L, He Y, Vi\u00f1olas N, S\u00e1nchez-Lorente D, Boada M et al (2022) Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor-Draining Vein Identifies miR-203a-3p as a Relapse Biomarker for Resected Non-Small Cell Lung Cancer. Int J Mol Sci 23:7138","journal-title":"Int J Mol Sci"},{"key":"10121_CR9","doi-asserted-by":"publisher","first-page":"215867","DOI":"10.1016\/j.canlet.2022.215867","volume":"547","author":"Y Hu","year":"2022","unstructured":"Hu Y, Lu Y, Xing F, Hsu W (2022) FGFR1\/MAPK-directed brachyury activation drives PD-L1-mediated immune evasion to promote lung cancer progression. Cancer Lett 547:215867","journal-title":"Cancer Lett"},{"key":"10121_CR10","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1002\/mco2.191","volume":"4","author":"L Huang","year":"2023","unstructured":"Huang L, Wang F, Wang X, Su C, Wu S, Yang C et al (2023) M2-like macrophage-derived exosomes facilitate metastasis in non-small-cell lung cancer by delivering integrin \u03b1V\u03b23. MedComm (2020) 4:e191","journal-title":"MedComm (2020)"},{"key":"10121_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12943-021-01411-w","volume":"20","author":"C Jiang","year":"2021","unstructured":"Jiang C, Zhang N, Hu X, Wang H (2021) Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms. Mol Cancer 20:117","journal-title":"Mol Cancer"},{"key":"10121_CR12","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.2147\/IJN.S272378","volume":"15","author":"VC Kok","year":"2020","unstructured":"Kok VC, Yu CC (2020) Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development. Int J Nanomed 15:8019\u20138036","journal-title":"Int J Nanomed"},{"key":"10121_CR13","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/ijms24021337","volume":"24","author":"SV Krylova","year":"2023","unstructured":"Krylova SV, Feng D (2023) The Machinery of Exosomes: Biogenesis, Release, and Uptake. Int J Mol Sci 24:1337","journal-title":"Int J Mol Sci"},{"key":"10121_CR14","first-page":"1167","volume":"37","author":"Z Li","year":"2022","unstructured":"Li Z, Wang YJ, Zhou J, Umakoshi M, Goto A (2022) The prognostic role of M2 tumor-associated macrophages in non-small-cell lung cancer. Histol Histopathol 37:1167\u20131175","journal-title":"Histol Histopathol"},{"key":"10121_CR15","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, Ren L, Li S, Li W, Zheng X, Yang Y et al (2021) The biology, function, and applications of exosomes in cancer. Acta Pharm Sin B 11:2783\u20132797","journal-title":"Acta Pharm Sin B"},{"key":"10121_CR16","doi-asserted-by":"publisher","first-page":"104577","DOI":"10.1016\/j.cellimm.2022.104577","volume":"379","author":"M Lu","year":"2022","unstructured":"Lu M, Wang K, Ji W, Yu Y, Li Z, Xia W et al (2022) FGFR1 promotes tumor immune evasion via YAP-mediated PD-L1 expression upregulation in lung squamous cell carcinoma. Cell Immunol 379:104577","journal-title":"Cell Immunol"},{"key":"10121_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12964-022-00872-w","volume":"21","author":"Y Lu","year":"2023","unstructured":"Lu Y, Han G, Zhang Y, Zhang L, Li Z, Wang Q et al (2023) M2 macrophage-secreted exosomes promote metastasis and increase vascular permeability in hepatocellular carcinoma. Cell Commun Signal 21:299","journal-title":"Cell Commun Signal"},{"key":"10121_CR18","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.3390\/molecules23092191","volume":"23","author":"IY Luk","year":"2018","unstructured":"Luk IY, Reehorst CM, Mariadason JM (2018) ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer. Molecules 23:2191","journal-title":"Molecules"},{"key":"10121_CR19","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s10528-023-10531-5","volume":"62","author":"D Ma","year":"2024","unstructured":"Ma D, Wu J, Chen C, Niu Y, Ji K, Xiao Y et al (2024) M2 Macrophage-Derived Exosomes Regulate miR-199a-3p Promoter Methylation Through the LINC00470-Mediated myc\/DNMT3a Axis to Promote Breast Cancer Development. Biochem Genet 62:2082\u20132099","journal-title":"Biochem Genet"},{"key":"10121_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fcell.2020.00079","volume":"8","author":"M Mossahebi-Mohammadi","year":"2020","unstructured":"Mossahebi-Mohammadi M, Quan M, Zhang JS, Li X (2020) FGF Signaling Pathway: A Key Regulator of Stem Cell Pluripotency. Front Cell Dev Biol 8:79","journal-title":"Front Cell Dev Biol"},{"key":"10121_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0378-1119(02)01156-3","volume":"303","author":"T Oikawa","year":"2003","unstructured":"Oikawa T, Yamada T (2003) Molecular biology of the Ets family of transcription factors. Gene 303:11\u201334","journal-title":"Gene"},{"key":"10121_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/1874471016666230829100703","volume":"17","author":"K Ozan","year":"2024","unstructured":"Ozan K, Fadime D (2024) An Investigation of the Relationship Between 18 F-FDG PET\/CT Parameters of Primary Tumors and Lymph Node Metastasis in Resectable Non-small Cell Lung Cancer. Curr Radiopharmaceut 17:111\u2013116","journal-title":"Curr Radiopharmaceut"},{"key":"10121_CR23","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/cells9051303","volume":"9","author":"A Pritchard","year":"2020","unstructured":"Pritchard A, Tousif S, Wang Y, Hough K, Khan S, Strenkowski J et al (2020) Lung Tumor Cell-Derived Exosomes Promote M2 Macrophage Polarization. Cells 9:1303","journal-title":"Cells"},{"key":"10121_CR24","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s10238-022-00888-z","volume":"23","author":"R Qin","year":"2023","unstructured":"Qin R, Ren W, Ya G, Wang B, He J, Ren S et al (2023) Role of chemokines in the crosstalk between tumor and tumor-associated macrophages. Clin Exp Med 23:1359\u20131373","journal-title":"Clin Exp Med"},{"key":"10121_CR25","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1200\/JCO.21.01497","volume":"40","author":"M Reck","year":"2022","unstructured":"Reck M, Remon J, Hellmann MD (2022) First-Line Immunotherapy for Non-Small-Cell Lung Cancer. J Clin Oncol 40:586\u2013597","journal-title":"J Clin Oncol"},{"key":"10121_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/mc.23378","volume":"61","author":"MN Rizwan","year":"2022","unstructured":"Rizwan MN, Ma Y, Nenkov M, Jin L, Schr\u00f6der DC, Westermann M et al (2022) Tumor-derived exosomes: Key players in non-small cell lung cancer metastasis and their implication for targeted therapy. Mol Carcinog 61:269\u2013280","journal-title":"Mol Carcinog"},{"key":"10121_CR27","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.3390\/cancers13174330","volume":"13","author":"A Sand\u00faa","year":"2021","unstructured":"Sand\u00faa A, Alegre E, Gonz\u00e1lez \u00c1 (2021) Exosomes in Lung Cancer: Actors and Heralds of Tumor Development. Cancers (Basel) 13:4330","journal-title":"Cancers (Basel)"},{"key":"10121_CR28","first-page":"437","volume":"21","author":"M Sema","year":"2024","unstructured":"Sema M, Serap Ozer Y, Okan A, Osman A, Irem Bozbey M, Ceylan H (2024) Determination of FGFR1 Functions in Cytarabine Treatment of Acute Myeloid Leukemia Through Bioinformatics Analysis. Curr Proteom 21:437\u2013448","journal-title":"Curr Proteom"},{"key":"10121_CR29","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00428-014-1634-2","volume":"465","author":"AN Seo","year":"2014","unstructured":"Seo AN, Jin Y, Lee HJ, Sun PL, Kim H, Jheon S et al (2014) FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer. Virchows Arch 465:547\u2013558","journal-title":"Virchows Arch"},{"key":"10121_CR30","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"10121_CR31","doi-asserted-by":"publisher","first-page":"e2309298","DOI":"10.1002\/advs.202309298","volume":"11","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang J, Shi H, Wang M, Yu D, Fu M et al (2024) M2 Tumor-Associated Macrophages-Derived Exosomal MALAT1 Promotes Glycolysis and Gastric Cancer Progression. Adv Sci (Weinh) 11:e2309298","journal-title":"Adv Sci (Weinh)"},{"key":"10121_CR32","doi-asserted-by":"publisher","first-page":"111670","DOI":"10.1016\/j.cellsig.2025.111670","volume":"129","author":"S Wei","year":"2025","unstructured":"Wei S, Zhao S, Yang W, Zhou J, Xu G, Zhang C et al (2025) EHF promotes liver cancer progression by meditating IL-6 secretion through transcription regulation of KDM2B in TAMs. Cell Signal 129:111670","journal-title":"Cell Signal"},{"key":"10121_CR33","doi-asserted-by":"publisher","first-page":"923","DOI":"10.4049\/jimmunol.2400335","volume":"213","author":"TL Whiteside","year":"2024","unstructured":"Whiteside TL (2024) Tumor-derived Exosomes and Antitumor Immunity. J Immunol 213:923\u2013931","journal-title":"J Immunol"},{"key":"10121_CR34","first-page":"102","volume":"5","author":"J Wu","year":"2022","unstructured":"Wu J, Li S, Zhang P (2022) Tumor-derived exosomes: immune properties and clinical application in lung cancer. Cancer Drug Resist 5:102\u2013113","journal-title":"Cancer Drug Resist"},{"key":"10121_CR35","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41417-023-00661-8","volume":"30","author":"L Xu","year":"2023","unstructured":"Xu L, Li K, Li J, Xu F, Liang S, Kong Y et al (2023) M2 macrophage exosomal LINC01001 promotes non-small cell lung cancer development by affecting METTL3 and glycolysis pathway. Cancer Gene Ther 30:1569\u20131580","journal-title":"Cancer Gene Ther"},{"key":"10121_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41389-019-0151-1","volume":"8","author":"Y Yang","year":"2019","unstructured":"Yang Y, Li Z, Yuan H, Ji W, Wang K, Lu T et al (2019) Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer. Oncogenesis 8:50","journal-title":"Oncogenesis"},{"key":"10121_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/0115701646309538240805093732","volume":"21","author":"Y Yue","year":"2024","unstructured":"Yue Y, Yiying T, Jiaxin W, Shidi Z, Fan Z, Lei S et al (2024) Circulating Exosomes Studied by Label-free Proteomics Analysis Reveal Transition Signatures from Diabetes Mellitus to Diabetic Kidney Disease. Curr Proteom 21:187\u2013203","journal-title":"Curr Proteom"},{"key":"10121_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/gutjnl-2020-321952","volume":"71","author":"T Zhou","year":"2022","unstructured":"Zhou T, Liu J, Xie Y, Yuan S, Guo Y, Bai W et al (2022) ESE3\/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4. Gut 71:357\u2013371","journal-title":"Gut"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10121-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-026-10121-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10121-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:45:21Z","timestamp":1786427121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-026-10121-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10121"],"URL":"https:\/\/doi.org\/10.1007\/s10863-026-10121-1","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Animal Care and Use Committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University approved the study. The animal study strictly followed the ARRIVE guidelines and the 3Rs principle (Replacement, Reduction, Refinement).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"47"}}